Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid Stenting
NCT ID: NCT04091074
Last Updated: 2021-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
26 participants
INTERVENTIONAL
2022-01-01
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ticagrelor Versus Clopidogrel in Carotid Artery Stenting
NCT02677545
Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm
NCT02675205
Efficacy and Safety of Low-dose Ticagrelor
NCT03381742
Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI
NCT02012140
A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin
NCT00528411
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
aspirin + ticagrelor before carotid stenting
patients undergoing carotid stenting take aspirin 150 mg + ticagrelor 90mg for 15 days before carotid stenting
Ticagrelor
Half of patients undergoing carotid stenting take ticagrelor+aspirin
Carotid stenting
Patients with carotid stenosis will undergo carotid stenting
aspirin + clopidogrel before carotid stenting
patients undergoing carotid stenting take aspirin 150 mg + clopidogrel 75 mg for 15 days before carotid stenting
Clopidogrel
Other half ofpatients undergoing carotid stenting take clopidogrel+aspirin
Carotid stenting
Patients with carotid stenosis will undergo carotid stenting
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ticagrelor
Half of patients undergoing carotid stenting take ticagrelor+aspirin
Clopidogrel
Other half ofpatients undergoing carotid stenting take clopidogrel+aspirin
Carotid stenting
Patients with carotid stenosis will undergo carotid stenting
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. More than 18 years.
3. Accepting all study requirements.
Exclusion Criteria
2. bleeding tendency or liver diseases
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Osama Ibrahim Aboelfath Ibrahim
Osama Ibrahim Aboelfath Ibrahim
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ticagrelor in carotid stenting
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.